Interview: “Democratic deliberation” and bioethics
By Nelson Michael & Xavier Symons,
BioEdge
| 06. 08. 2016
With an election round the corner, the Presidential Commission for the Study of Bioethical Issues is coming to the end of its term. The Commission recently released its final report, entitled Bioethics for Every Generation: Deliberation and Education in Health, Science and Technology. The report discusses the complexities bioethical decision-making in an age of deep ideological disagreements and rapid biomedical progress. The Commission members are optimistic, suggesting that agreement can be reached on substantive bioethical policy matters through processes of “democratic deliberation”. The report proposes an ambitious educational program to improve the bioethical literacy of the public, and also outlines a series of civic virtues that policy stakeholders should adopt when debating ethical issues.
Last week Xavier Symons, of BioEdge, conducted an email interview with Col. Nelson L. Michael, MD, PhD, about the report and the future of bioethics in the United States. Col. Michael is a PCSBI member, and also Director of the U.S. Military HIV Research Program at Walter Reed Army Institute of Research.
******
BioEdge: Hillary Clinton and Donald Trump are the likely candidates for the...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...